LCN2 and acute kidney injury: Unlike specialized biomarkers such as procalcitonin or novel AKI markers (neutrophil gelatinase-associated lipocalin, cystatin C), CAR components (creatinine and albumin) are routinely measured in virtually all hospitalized patients, available 24/7 in most clinical laboratories, and incur minimal additional costs.